The Berlin Center for Epidemiology and Health Research (ZEG Berlin: acronym for the German name: Zentrum für Epidemiologie & Gesundheitsforschung) was founded in 1990.
It has its roots in the first Epidemiology Research Centre for non-communicable diseases in Germany, i.e. the founding key persons of ZEG and many employees had rich experience in non-communicable disease epidemiology and prevention since the late 1960. Currently, the main focus of the institute is research in Pharmacoepidemiology and Drug Surveillance.
ZEG and ENCePP
We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.
Short description . . . more
ZEG Berlin is an independent (private) research institute with a main focus on pharmacoepidemiology and outcomes research, particularly on drug safety and risk management/ minimization (see organizational chart)
Specialty: large multinational observational studies based on existing networks of experienced collaborators/physicians and their patients in Europe, North America or elsewhere that can be completed or amended on short notice if desirable. Epidemiological /pharmacoepidemiological studies can be setup fast and cost-efficiently for all indications of new and also older substances which are already longer in the market. It is even possible saddling up on already running studies..
Structure and scope . . . more
ZEG is affiliated with the globally operating Kantar (Healthcare) Group wich has over 40 offices throughout the Americas, Europe, Asia-Pacific, the Middle East and Africa.